Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Inventory Average: 2023-2025

Historic Inventory Average for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Sep 2025 value amounting to $20.5 million.

  • Rhythm Pharmaceuticals' Inventory Average rose 58.29% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 58.29%. This contributed to the annual value of $13.7 million for FY2024, which is 137.11% up from last year.
  • Rhythm Pharmaceuticals' Inventory Average amounted to $20.5 million in Q3 2025, which was up 7.31% from $19.1 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Inventory Average high stood at $20.5 million for Q3 2025, and its period low was $4.2 million during Q1 2023.
  • Over the past 3 years, Rhythm Pharmaceuticals' median Inventory Average value was $10.3 million (recorded in 2024), while the average stood at $12.0 million.
  • Data for Rhythm Pharmaceuticals' Inventory Average shows a peak YoY soared of 122.15% (in 2025) over the last 5 years.
  • Rhythm Pharmaceuticals' Inventory Average (Quarterly) stood at $8.2 million in 2023, then surged by 99.17% to $16.3 million in 2024, then soared by 58.29% to $20.5 million in 2025.
  • Its last three reported values are $20.5 million in Q3 2025, $19.1 million for Q2 2025, and $19.0 million during Q1 2025.